North America Exoskeleton Market Size & Outlook, 2026-2033
The exoskeleton market in North America is expected to reach a projected revenue of US$ 722.1 million by 2033. A compound annual growth rate of 13.3% is expected of North America exoskeleton market from 2026 to 2033.
The North America exoskeleton market generated a revenue of USD 260.2 million in 2025.
The market is expected to grow at a CAGR of 13.3% from 2026 to 2033.
In terms of segment, mobile was the largest revenue generating mobility in 2025.
Fixed/Stationary is the most lucrative mobility segment registering the fastest growth during the forecast period.
Country-wise, Canada is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
Market revenue in 2025
USD 260.2 million
Market revenue in 2033
USD 722.1 million
Growth rate
13.3% (CAGR from 2026 to 2033)
Largest segment
Mobile
Fastest growing segment
Fixed/Stationary
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Mobile, Fixed/Stationary
Key market players worldwide
Ekso Bionics Holdings Inc, Armastec, Hocoma, Lockheed Martin Corp, Rex Bionics, RB3D, Rewalk Robotics Ltd, Cyberdyne Inc, Activelink, DIH Medical
Other key industry trends
In terms of revenue, North America region accounted for 44.1% of the exoskeleton market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 533.6 million by 2033.
North America led the market in 2024, capturing 45.13% of the revenue and 26.32% of the volume share, driven by increasing investment in research, a growing disabled population, and expanding partnerships among key players, availability of advanced technologies, and strong public and private sector support.
For instance, in March 2021, Ekso Bionics, an exoskeleton technology company, partnered with U.S. Physiatry (USP) to educate clinicians or physicians on the clinical benefits of an EksoNR exoskeleton.
Moreover, rising disposable income, a rapidly growing geriatric population, widespread presence of key market players, growing human augmentation in industry and military verticals, and availability of public & private investors are driving the growth.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exoskeleton Market Outlook will help companies and investors design strategic landscapes.
Mobile was the largest segment with a revenue share of 73.52% in 2025.
Horizon Databook has segmented the North America exoskeleton market based on mobile, fixed/stationary covering the revenue growth of each sub-segment from 2021 to 2033.
North America led the market in 2024, capturing 45.13% of the revenue and 26.32% of the volume share, driven by increasing investment in research, a growing disabled population, and expanding partnerships among key players, availability of advanced technologies, and strong public and private sector support.
For instance, in March 2021, Ekso Bionics, an exoskeleton technology company, partnered with U.S. Physiatry (USP) to educate clinicians or physicians on the clinical benefits of an EksoNR exoskeleton.
Moreover, rising disposable income, a rapidly growing geriatric population, widespread presence of key market players, growing human augmentation in industry and military verticals, and availability of public & private investors are driving the growth.
North America Exoskeleton Market Mobility Outlook (Revenue, USD Million , 2021-2033)
Mobile
Fixed/Stationary
North America Exoskeleton Market Technology Outlook (Revenue, USD Million , 2021-2033)
Powered
Non-powered
North America Exoskeleton Market Extremity Outlook (Revenue, USD Million , 2021-2033)
Upper Body
Lower Body
Full Body
North America Exoskeleton Market End Use Outlook (Revenue, USD Million , 2021-2033)
Healthcare
Military
Industry
Reasons to subscribe to Exoskeleton Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exoskeleton Market Outlook databook
Our clientele includes a mix of Exoskeleton Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Exoskeleton Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Exoskeleton Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Exoskeleton Market, 2021-2033 (US$M)